Rankings
▼
Calendar
DXCM Q4 2023 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena
DXCM
DexCom, Inc.
$27B
Q4 2023 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$1.0B
+26.9% YoY
Gross Profit
$657M
63.5% margin
Operating Income
$217M
21.0% margin
Net Income
$256M
24.8% margin
EPS (Diluted)
$0.62
QoQ Revenue Growth
+6.1%
Cash Flow
Operating Cash Flow
$134M
Free Cash Flow
$81M
Stock-Based Comp.
$37M
Balance Sheet
Total Assets
$6.3B
Total Liabilities
$4.2B
Stockholders' Equity
$2.1B
Cash & Equivalents
$566M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.0B
$815M
+26.9%
Gross Profit
$657M
$541M
+21.3%
Operating Income
$217M
$125M
+73.0%
Net Income
$256M
$92M
+179.2%
Geographic Segments
UNITED STATES
$769M
74%
Non-US
$265M
26%
← FY 2023
All Quarters
Q1 2024 →